FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery, thanks to a wide range of innovative ophthalmic devices such as self-retaining intubation sets, lacrimal balloon catheter, injectable monocanalicular intubation, permanent punctal plugs, eyelids and orbital implants.
The wrapping technique consists to wrap a bioceramic orbital implant with a resorbable mesh. This procedure facilitates both placement of the orbital implant into the eye socket and also muscles suturing. Additionally, the wrapping technique take a few minutes to perform and avoid the use of donor material.
FCI Bioceramic orbital implants have become the new standard in orbital implant material. These implants have an improved vascularization structure over other existing alternatives, allowing for quick fibrovascularization.